Novocure LTD DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
NVCR
Novocure LTDNovoCure Limited has filed its definitive proxy statement for the 2026 Annual General Meeting of Shareholders to be held on June 3, 2026.
NASDAQ
NVCR
Novocure LTDNovoCure Limited has scheduled its annual shareholder meetings for June 5, 2024, and June 4, 2025, with proxy materials available online and via mail.
NASDAQ
NVCR
Novocure LTDNovoCure has announced its Annual General Meeting of Shareholders to be held on June 4, 2025, featuring proposals including director elections, auditor ratification, executive compensation approval, and the approval of the 2025 Employee Share Purchase Plan.
NASDAQ
NVCR
Novocure LTDNovoCure Limited has scheduled its 2024 Annual Meeting for June 5, 2024, and is providing proxy materials to shareholders for voting on key proposals.
NASDAQ
NVCR
Novocure LTDNovoCure is asking shareholders to approve the 2024 Omnibus Incentive Plan to replace the 2015 plan, aiming to continue attracting and retaining key talent through equity-based awards.